1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Summary of primary HNSCC tumor sites evaluated
Primary Site No. of Patients Untreated tumors (n = 22) Larynx 7a Hypopharynx 1 Retromolar trigone, anterior tonsillar pillar 3 Oral cavity, other 5 Oropharynx, other 3 Sinuses, nose 3 Recurrent or metastatic tumors (n = 8) HNSCC invading parotid (n = 2), parapharyngeal space metastasis, oral cavity (n = 2), base of tongue, cheek, neopharynx
↵a Three of 7 laryngeal tumors had pathologically proven thyroid cartilage invasion.